SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop, and deliver potentially curative therapies for heart disease, revealed that Faraz Ali, the company’s Chief Executive Officer, will engage in a fireside chat during the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 4:50 pm ET. Tenaya Therapeutics, known for its commitment to addressing the root causes of heart disease, eagerly anticipates this opportunity to discuss its groundbreaking work on a global platform.
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
-
Flamengo and PSG have faced each other three times; check out their record
-
Indonesia Open Footgolf Tournament: Comedian Oki Rengga Admits Addiction, Wants to Become a Professional Athlete
-
Shameful Incident in Punjab! Landlord Rolls Tenant’s Daughter
-
Virgil van Dijk Expresses Desire for Mohamed Salah to Stay at Liverpool
Deixe um comentário